Literature DB >> 24692830

Adjusting the basal insulin regimen of patients with type 1 diabetes mellitus receiving insulin pump therapy during the Ramadan fast: A case series in adolescents and adults.

Yousra M A Hawli1, Mira S Zantout2, Sami T Azar1.   

Abstract

BACKGROUND: Ramadan, the ninth month of the Islamic lunar calendar, is the holy month of fasting for adolescent and adult Muslims. Observance of Ramadan is considered obligatory for every healthy adult Muslim. During this time, Muslims refrain from eating, drinking, smoking, and administering oral or parenteral medications from sunrise to sunset daily for 28 to 30 days. CASE
SUMMARY: We evaluated the need for changes in basal insulin regimen in 5 patients (4 males and 1 female; age range, 15-19 years) with type 1 diabetes mellitus (T1DM) who fasted during Ramadan. The patients were receiving insulin pump therapy with regular human insulin and maintained weekly visits with their endocrinologist at The Chronic Care Center (Beirut, Lebanon). They were instructed to break the fast after any episode of hypoglycemia (finger stick glucose <70 mg/dL) or severe hyperglycemia (finger stick glucose ≥300 mg/dL or any hyperglycemia associated with presence of urine ketone bodies on urinary dipstick). Blood glucose concentrations did not change significantly with fasting. Finger stick blood glucose taken at 4-hour intervals decreased in the afternoon (at 4 pm) and increased in the evening and morning (10 pm and 8 am, respectively) during this month in 4 of 5 patients, while no significant change in circadian rhythm of finger stick blood glucose was observed in 1 patient. Based on the investigators' findings, the basal insulin requirement decreased by 5.5% to 25.0% (4 patients) or did not change (1 patient) during the fast. Changes in regimens, based on collaboration between the endocrinologist and diabetes educational nurse, were determined by blood glucose self-monitoring done at 4-hour intervals during the fasting period, pre-Suhur (predawn breakfast), and ≥2 hours after Iftar (evening fast-breaking meal). No cases of keto-acidosis or severe hypoglycemia were reported.
CONCLUSION: These 5 adolescent and adult patients with T1DM who were using an insulin pump were able to fast during Ramadan without incidences of severe hypoglycemia or ketoacidosis by using close blood glucose self-monitoring and weekly follow-up with their endocrine team, which consisted of an endocrinologist, a registered nutritionist, and a diabetes educational nurse.

Entities:  

Keywords:  Ramadan fasting; blood glucose concentration; diabetes control; insulin pump therapy; type 1 diabetes

Year:  2009        PMID: 24692830      PMCID: PMC3969982          DOI: 10.1016/j.curtheres.2009.02.001

Source DB:  PubMed          Journal:  Curr Ther Res Clin Exp        ISSN: 0011-393X


  9 in total

1.  The fast of Ramadan.

Authors:  A H Rashed
Journal:  BMJ       Date:  1992-02-29

Review 2.  Recommendations for management of diabetes during Ramadan.

Authors:  Monira Al-Arouj; Radhia Bouguerra; John Buse; Sherif Hafez; Mohamed Hassanein; Mahmoud Ashraf Ibrahim; Faramarz Ismail-Beigi; Imad El-Kebbi; Oussama Khatib; Suhail Kishawi; Abdulrazzaq Al-Madani; Aly A Mishal; Masoud Al-Maskari; Abdalla Ben Nakhi; Khaled Al-Rubean
Journal:  Diabetes Care       Date:  2005-09       Impact factor: 19.112

3.  Insulin therapy during Ramadan fast for Type 1 diabetes patients.

Authors:  H S Kassem; M S Zantout; S T Azar
Journal:  J Endocrinol Invest       Date:  2005-10       Impact factor: 4.256

4.  Insulin therapy during Ramadan fast for patients with type 1 diabetes mellitus.

Authors:  Sami T Azar; Walid G Khairallah; Marie T Merheb; Mira S Zantout; Fadl Fliti
Journal:  J Med Liban       Date:  2008 Jan-Mar

Review 5.  Management of people with diabetes during Ramadan.

Authors:  Rukiye Pinar
Journal:  Br J Nurs       Date:  2002 Nov 14-27

Review 6.  Diabetes and Ramadan: review of the literature.

Authors:  B Benaji; N Mounib; R Roky; N Aadil; I E Houti; S Moussamih; S Maliki; B Gressier; H El Ghomari
Journal:  Diabetes Res Clin Pract       Date:  2006-05-02       Impact factor: 5.602

7.  Treatment of type 1 diabetes with insulin lispro during Ramadan.

Authors:  A Kadiri; A Al-Nakhi; S El-Ghazali; A Jabbar; M Al Arouj; J Akram; J Wyatt; A Assem; S Ristic
Journal:  Diabetes Metab       Date:  2001-09       Impact factor: 6.041

8.  [Diabetic ketoacidosis during the Ramadan fast].

Authors:  I Friedrich; Y Levy
Journal:  Harefuah       Date:  2000-01-02

9.  A population-based study of diabetes and its characteristics during the fasting month of Ramadan in 13 countries: results of the epidemiology of diabetes and Ramadan 1422/2001 (EPIDIAR) study.

Authors:  Ibrahim Salti; Eric Bénard; Bruno Detournay; Monique Bianchi-Biscay; Corinne Le Brigand; Céline Voinet; Abdul Jabbar
Journal:  Diabetes Care       Date:  2004-10       Impact factor: 19.112

  9 in total
  4 in total

1.  Safety of Ramadan fasting in young patients with type 1 diabetes: A systematic review and meta-analysis.

Authors:  Huai Heng Loh; Lee-Ling Lim; Huai Seng Loh; Anne Yee
Journal:  J Diabetes Investig       Date:  2019-04-26       Impact factor: 4.232

2.  Impact of Ramadan Diurnal Intermittent Fasting on Hypoglycemic Events in Patients With Type 2 Diabetes: A Systematic Review of Randomized Controlled Trials and Observational Studies.

Authors:  Dana Abdelrahim; MoezAlIslam E Faris; Mohamed Hassanein; Ayman Z Shakir; Ayesha M Yusuf; Aljohara S Almeneessier; Ahmed S BaHammam
Journal:  Front Endocrinol (Lausanne)       Date:  2021-03-08       Impact factor: 5.555

Review 3.  Diabetes and Ramadan: A concise and practical update.

Authors:  Mohamed H Ahmed; Nazik Elmalaika Husain; Wadie M Elmadhoun; Sufian K Noor; Abbas A Khalil; Ahmed O Almobarak
Journal:  J Family Med Prim Care       Date:  2017 Jan-Mar

4.  Attitudes and habits of patients with type 1 diabetes during fasting Ramadan.

Authors:  Reem Alamoudi; Maram Alsubaiee; Ali Alqarni; Saleh Aljaser; Yousef Saleh; Abdul Salam; Mohsen Eledrisi
Journal:  J Clin Transl Endocrinol       Date:  2018-09-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.